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Ventral Neurogenesis Minireview
and the Neuron-Glial Switch
defining the neuroepithelial domain that gives rise to
MNs and, in combination with the neurogenic bHLH pro-
tein Neurogenin2 (Ngn2), is required to specify MN fate.
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Wolfson Institute for Biomedical Research and
Department of Biology Intriguingly, oligodendrocyte progenitors (OLPs) orig-
University College London inate from the same region of the ventral neuroepithel-
Gower Street ium that at earlier times gave rise to MNs and/or V3
London WC1E 6AE interneurons (Soula et al., 2001; Richardson et al., 2000;
United Kingdom Sun et al., 1998, Xu et al., 2000). How do these precursors
suddenly switch from neuron to OLP production? The
studies by Mizuguchi et al. (2001) and Novitch et al.
(2001) together with the accompanying article by ZhouIn the developing spinal cord, neuroepithelial precur-
et al. (2001 [this issue of Neuron]) suggest an elegantsors at different positions along the dorsal-ventral axis
mechanism. A temporal shift of gene expression pat-generate distinct neuronal and glial subtypes. For ex-
terns in the ventral cord provides Olig2 with successiveample, one group of ventral precursors generates neu-
regulatory partners, first Ngn1/2 and Pax6, and thenrons followed by oligodendrocytes. A spate of recent
Nkx2.2. In collaboration with these factors, Olig2 firstarticles, including several in this issue of Neuron, are
specifies MNs, then OLPs.devoted to the mechanisms governing neuronal and
Specification of Neuronal Subtype by Repressionglial subtype specification in the ventral cord. We re-
of Alternative Fatesview these studies and discuss the nature of the ven-
HD proteins in the ventral spinal cord have been classi-tral neuron-oligodendrocyte switch.
fied into two groups on the basis of their expression
patterns and mode of regulation by SHH. Class I proteinsDevelopment of the spinal cord begins with the forma-
(e.g., Pax6, Irx3) are repressed by Shh and are thereforetion of the neural tube and the establishment of signaling
expressed at a distance from the floor plate. In contrast,centers both inside and outside the cord. Sonic hedge-
class II proteins (e.g., Nkx2.2, Nkx6.1) are induced byhog (Shh) from the notochord and floor plate and mem-
Shh (Figure 1). A three-step model for neuronal specifi-bers of the transforming growth factor  family from the
cation in the ventral neural tube has been proposed:roof plate form opposing gradients of diffusible signaling
(1) Shh signaling initiates restrictions in the expressionmolecules along the dorsal-ventral axis. Together with
domains of HD proteins, (2) the subsequent sharpeninganalogous gradients along the anterior-posterior axis,
and maintenance of domain boundaries depends onthey establish a grid of positional information within the
crossregulatory interactions between class I and classcord. These extracellular cues are interpreted by precur-
II proteins, and (3) the combinatorial activities of classsor cells and converted into intracellular transcriptional
I and class II proteins within each domain specify neu-circuits that ultimately determine their differentiated cell
ronal subtype (Briscoe and Ericson, 2001; Jessell, 2000).fates.
More recently it has been shown that the class I andNeurons are generated early during neural tube devel-
class II proteins act directly as transcriptional repres-opment; glial cells (oligodendrocytes and astrocytes)
sors, via recruitment of Groucho (Gro) corepressorsare generated later. The progenitors of different species
(Muhr et al., 2001). This suggests that neuronal specifi-of neurons—motor neurons (MNs) or interneurons, for
cation is achieved by mutual repression of class I andexample—are formed within their own specialized neu-
class II proteins at progenitor domain boundaries, asroepithelial domains. How are these domains defined?
well as repression of downstream determinants of neu-Previous work has shown that ventral domains (of which
ronal cell fate (e.g., the MN-specific HD protein MNR2)there are five) are defined by sets of homeodomain (HD)
(Briscoe and Ericson, 2001; Muhr et al., 2001). Thus,transcription factors that are activated or repressed by
specification of neuronal subtype within a given neuro-different threshold concentrations of Shh (Briscoe et al.,
epithelial domain results from the repression of all other2000, 2001; Briscoe and Ericson, 2001; Jessell, 2000).
The particular set of HD factors expressed in each do- possible fates in that domain. For example, Pax6 re-
main regulates downstream genes that determine neu- presses Nkx2.2 expression, excluding it from the MN
ronal identity. An article by Vallstedt et al. (2001) in this progenitor domain (pMN) and restricting it to the V3
issue of Neuron reinforces this view and suggests that interneuron progenitor domain (p3) (Ericson et al., 1997).
duplication of HD genes and subsequent modification In the Small eye (Sey) mouse mutant, which lacks Pax6
of their regulatory interactions has been a driving force function, Nkx2.2 is derepressed and expands dorsally
for generating neuronal diversity in the spinal cord dur- into the pMN domain. There, Nkx2.2 represses MNs and
ing evolution. Two more papers by Mizuguchi et al. (2001 leads to V3 neuron generation. Thus, in normal mice,
[this issue of Neuron]) and Novitch et al. (2001 [also in Pax6 promotes the MN pathway in pMN by repressing
this issue of Neuron]) show that the recently discovered a repressor of MN fate—the regulatory equivalent of a
basic helix-loop-helix (bHLH) protein Olig2 is crucial for grammar built on double-negatives. This has been labeled
the derepression model of neuronal subtype specifica-
tion (Briscoe and Ericson, 2001; Muhr et al., 2001).1 Correspondence: w.richardson@ucl.ac.uk
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The bHLH transcription factors Olig1 and Olig2 were
recently identified in connection with oligodendrocyte
development (hence their names) (Lu et al., 2000; Take-
bayashi et al., 2000; Zhou et al., 2000). However, Olig2
is expressed in the pMN domain well ahead of the ap-
pearance of overt oligodendrocyte progenitors (OLPs),
suggesting a role for Olig2 in MN specification. Indeed,
Novitch et al. (2001) and Mizuguchi et al. (2001) demon-
strate that ectopic expression of Olig2 in the chick spinal
cord or hindbrain in ovo represses Irx3 expression and
vice versa. Thus, crossrepression between Olig2 and
Irx3 fixes the dorsal boundary of the pMN domain, defin-
ing them as a class I/class II pair. Olig2 is an unconven-
tional class II protein though because it is a bHLH pro-
tein, not an HD protein like all the others.
Interactions between HD and bHLH Transcription
Figure 1. Class I and Class II Repressors in the Ventral Spinal Cord Regulators in Neuronal Subtype Specification
All encoded proteins are homeodomain transcription factors except On top of the HD protein pathway of neuronal specifica-
for Olig2, which is a basic helix-loop-helix factor. Nkx6.2 expression tion, there appears to be a parallel neurogenic pathway
is restricted to the p1 domain in mouse (illustrated) but in chick involving bHLH proteins. bHLH genes in Drosophila and
overlaps Nkx6.1 down to the floor plate (dotted line).
vertebrates can direct pan-neuronal as well as subtype-
specific programs of differentiation (Guillemot, 1999). In
the vertebrate spinal cord, several bHLH genes (neuro-The Search for Predicted Repressor Proteins
genins, Mash1, Math1, Olig1/2) are expressed in discreteThe idea that neuroepithelial domain boundaries are
regions of the neuroepithelium. Mizuguchi et al. (2001)defined by crossinhibition between class I and class II
and Novitch et al. (2001) demonstrate that the expres-proteins predicts that there should be a class I/class II
sion pattern of Olig2 in the spinal cord is indeed regu-doublet assigned to every boundary. While a full set of
lated by HD proteins. In addition to the crossrepressiveclass I proteins has been identified, only two of these had
interactions between Olig2 and Irx3 at the pMN/P2 bor-known class II counterparts. The known class I/class II
der, Nkx6.1 appears to induce expression of Olig2 inpairs were Pax6/Nkx2.2 at the p3/pMN boundary and
pMN, and Nkx2.2 sets the ventral limit of Olig2 at theNkx6.1/Dbx2 at the p2/p1 boundary. Now, two “missing”
p3/pMN boundary (Novitch et al., 2001). The possibilityclass II proteins have been found: Vallstedt et al. (2001)
that HD and bHLH neurogenic pathways intersect wasshow that Nkx6.2 is a class II partner of Dbx1 at the p1/
also suggested by Scardigli et al. (2001). By studyingp0 interface and Novitch et al. (2001) identify Olig2 as
mice mutant for the HD protein Pax6 and Ngn2, theya putative class II partner of Irx3 at pMN/p2 (Figure 1).
found evidence for a two-way genetic interaction. Scar-
Nkx6.1 was previously shown to be a class II repressor
digli et al. (2001) further showed that Ngn2 is necessary
involved in the specification of V2 interneurons and MNs.
for proper MN specification. However Ngn2 is only a
With its class I counterpart, Dbx2, it defines the position
permissive component of the MN pathway and is likely
of the p1/p2 boundary. Mice lacking Nkx6.1 have no V2 to interact with other transcription factors that might
interneurons and a reduced number of MNs (Sander et have more restricted expression patterns and more spe-
al., 2000). Vallstedt et al. (2001) demonstrate that the cific roles in neuronal subtype specification.
reduction—rather than complete loss—of MNs is due Mizuguchi et al. (2001) and Novitch et al. (2001) now
to a ventral expansion of Nkx6.2 expression into the p2 further define the role of Ngn2 in MN generation and
and pMN domains, where it compensates for the loss demonstrate that it collaborates with Olig2 to direct the
of Nkx6.1. In keeping with this functional redundancy expression of both pan-neuronal and MN-specific char-
between Nkx6 proteins, ectopic expression of either acteristics. They report that expression of Olig2 in the
Nkx6.1 or Nkx6.2 in the chick spinal cord induces ectopic neural tube precedes that of Ngn2. At the time of MN
MN production. Note that Nkx6.2 fails to substitute for generation, Ngn2 is expressed strongly in the pMN do-
Nkx6.1 in the p2 domain of the Nkx6.1 knockout. This is main, suggesting that Olig2 may influence its expres-
because Nkx6.2, being a weaker repressor than Nkx6.1, sion. Indeed, ectopic expression of Olig2 in the chick
allows Dbx2 expression to expand ventrally into p2 spinal cord and hindbrain showed that Olig2 leads to
where it blocks V2 production. upregulation of Ngn2 and induction of cells expressing
Apart from their redundant functions, Nkx6.1 and MN differentiation markers. Loss-of-function studies by
Nkx6.2 also have distinct functions. In the normal mouse expression of a putative dominant-negative form of
spinal cord, Nkx6.2 expression is restricted to the p1 Olig2 (Olig2 bHLH domain fused to the transactivation
domain just dorsal to Nkx6.1. The dorsal boundary of domain of Herpes Virus Protein VP16) in the pMN domain
Nkx6.2 expression coincides with the ventral limit of caused a reduction in the number of cells expressing
Dbx1, suggesting that these genes might form another MNR2/Lim3/HB9 within pMN, indicating that the activity
class I/class II doublet. Vallstedt et al. (2001) confirm this of endogenous Olig2 is indeed essential for MN gener-
by demonstrating that in Nkx6.2 null mice, expression of ation.
Dbx1 expands ventrally into the p1 domain and induces In addition, Novitch et al. (2001) ectopically expressed
ectopic V0 neurons. Nkx6.2 therefore fits the bill as a a hybrid protein comprising the bHLH domain of Olig2
fused to the repressor domain of the Drosophila En-bona fide class II partner of Dbx1.
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Figure 2. The Neuron-Oligodendrocyte Fate
Switch in Chick Spinal Cord
At early times (E3–E5 chick) motor neurons
are generated from the pMN domain under
the influence of Olig2 in conjunction with
Ngns. Later (E6–E7), Ngn1 and Ngn2 are dow-
nregulated in this part of the cord. Subse-
quently, the expression domains of Nkx2.2
and Olig2 shift relative to one another and
generate a region of overlap. This triggers a
switch in the activity of Olig2 in the overlap,
which now generates oligodendrocyte pro-
genitors (OLPs). Note that the situation is dif-
ferent in mouse (see text).
grailed protein (EnR). They found that this hybrid protein epithelium precedes the dorsal expansion of Nkx2.2
expression in vivo. Nevertheless, it seems an inherentlywas able to mimic the activity of genuine Olig2 in re-
pressing Irx3 and inducing MN markers, suggesting that attractive and likely scenario that downregulation of
Ngns by whatever mechanism is a key event in theOlig2 acts as a direct transcriptional repressor like other
class I and class II proteins. In contrast, Mizuguchi et switch from neuronal to glial cell fate specification.
What is the role of Nkx2.2 in OLP development inal. (2001) found that an Olig2-EnR hybrid repressor was
unable to substitute for wild-type Olig2 in inducing MN vivo if not to downregulate Ngns? There is a significant
difference between the activities of Nkx2.2 and thedifferentiation. This discrepancy will be clarified in future
by identification of direct targets of Olig2 and Ngn2 as Notch signaling pathway in OLP specification. Ectopic
Nkx2.2 in collaboration with Olig2 drives production notwell as true loss-of-function studies in knockout mice.
Nevertheless, it seems to be agreed that Ngn2 and Olig2 only of OLPs, defined by expression of Sox10 and PDGF
receptor- (PDGFRA), but of seemingly more differenti-collaborate in promoting MN generation by inducing
pan-neuronal and MN-specific features, respectively. ated stages of the lineage defined by myelin basic pro-
tein and myelin proteolipid protein (MBP and PLP). InThe Switch from MN to OLP Production
At around midgestation, when MN production ceases, contrast, Notch signaling together with Olig2 induces
OLPs but not MBP or PLP expression. It could be thatOLPs start to be produced from the ventral neuroepithe-
lium instead (Richardson et al., 2000; Miller, 1996). De- Nkx2.2 is normally required (in addition to Ngn downreg-
ulation) for myelin gene expression, not for OLP specifi-velopment of OLPs, like MNs before them, depends on
Shh signaling from the ventral midline. How is the switch cation per se. This would fit with the fact that, in rats
and mice, PDGFRA-positive OLPs are generated mainlyfrom neuronal to glial cell production orchestrated?
Zhou et al. (2001) have made some key observations outside the Nkx2.2 domain (Lu et al., 2000; Sun et al.,
1998) and do not express detectable levels of Nkx2.2that shed light on this question. They report that, shortly
after MN production has finished, the proneural bHLH as they migrate (N.P. and W.D.R., unpublished data);
however, after settling in white matter, differentiatingproteins Ngn1 and Ngn2 are downregulated in the ven-
tral neuroepithelium (Figure 2). Subsequently, the do- oligodendrocytes in both chicks and rodents express
Nkx2.2 strongly (Xu et al., 2000; N.P., N.K., and W.D.R.,mains of Nkx2.2 and Olig2 expression, which previously
were mutually exclusive, shift relative to one another unpublished data).
Remaining Questionsto create a region of overlap. Migratory (Olig2, Nkx2.2)
double-positive OLPs then appear within the overlap, Several intriguing questions remain. Early on, during MN
production, Nkx2.2 represses Olig2 and so defines itsdisperse throughout the spinal cord and differentiate
into postmitotic, myelinating oligodendrocytes in white ventral expression limit. How is it, then, that Nkx2.2 and
Olig2 can later be coexpressed in the same cells andmatter. These observations suggest that when the pan-
neurogenic program is turned off in the pMN domain, collaborate in oligodendrocyte development? Perhaps
Nkx2.2 can repress Olig2 only in the presence of Ngns.Olig2 acquires a new function in promoting OLP devel-
opment. By ectopic expression of Olig2 in the embryonic A major question to address in future is the nature of
the direct targets of Olig2, Nkx2.2, and Ngn2. This willchick spinal cord in ovo, Zhou et al. (2001) demonstrate
that Olig2 by itself is insufficient to induce OLPs unless be essential to understand how MN and OLP fates are
determined and indeed what kinds of molecular eventsNgn1 and Ngn2 are concurrently downregulated by
coexpression of either Nkx2.2 or constitutively active accompany cell fate specification in general.
In chick, both (Nkx2.2, Olig2) double-positive OLPscomponents of the Notch signaling pathway (Notch acti-
vation is known to repress Ngns in other developmental and Nkx2.2-positive, Olig2-negative cells appear to mi-
grate from neighboring regions of the ventral neuroepi-contexts).
It is unlikely that Nkx2.2 is responsible for downregu- thelium. Perhaps these represent different classes of
OLPs (Spassky et al., 2000). This is the explanation fa-lating Ngns during normal development because extinc-
tion of Ngn expression in the relevant part of the neuro- vored by Zhou et al. (2001). However, they could also
Neuron
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Spassky, N., Olivier, C., Perez-Villegas, E., Goujet-Zalc, C., Martinez,be late-migrating neurons or another class of glial cells—
S., Thomas, J., and Zalc, B. (2000). Glia 29, 143–148.possibly astrocyte progenitors. In mouse, there seem to
Sun, T., Pringle, N.P., Hardy, A.P., Richardson, W.D., and Smith,be separate Nkx2.2-positive and Nkx2.2-negative OLPs
H.K. (1998). Mol. Cell. Neurosci. 12, 228–239.from above and below the p3/pMN boundary (N.P., N.K.,
Sun, T., Echelard, Y., Lu, R., Yuk, D., Kaing, S., Stiles, C.D., andand W.D.R., unpublished data); do these give rise to
Rowitch, D.H. (2001). Curr. Biol., in press.
different types of oligodendrocytes? Do any other neu-
Takebayashi, H., Yoshida, S., Sugimori, M., Kosako, H., Kominami,roepithelial domains in the ventral or dorsal spinal cord
R., Nakafuku, M., and Nabeshima, Y. (2000). Mech. Dev. 99, 143–148.
switch from neuron to glial cell production—for example,
Tekki-Kessaris, N., Woodruff, R., Hall, A.C., Gaffield, W., Kimura, S.,
from neurons to astrocytes? Stiles, C.D., Rowitch, D.H., and Richardson, W.D. (2001). Develop-
What is the role of Olig1? In rodents, Olig1 is coex- ment 128, 2545–2554.
pressed with Olig2 in the ventral spinal cord. Gain-of- Vallstedt, A., Muhr, J., Pattyn, A., Pierani, A., Mendelsohn, M.,
function experiments in ventral regions of the mouse Sander, M., Jessell, T.M., and Ericson, J. (2001). Neuron 31, this
issue, 743–755.neural tube show that Olig1 inhibits production of V3
interneurons but not V2 interneurons or MNs (Sun et al., Xu, X., Cai, J., Fu, H., Wu, R., Qi, Y., Modderman, G., Liu, R., and
Qiu, M. (2000). Mol. Cell. Neurosci. 16, 740–753.2001). Does Olig1 have a contributory role in neuron-
Zhou, Q., Wang, S., and Anderson, D.J. (2000). Neuron 25, 331–343.glial switching or in OLP generation? Another recent
Zhou, Q., Choi, G., and Anderson, D.J. (2001). Neuron 31, this issue,study shows that when ectopically expressed in the
791–807.mouse neocortex in vivo, Olig1 generates a mixture of
oligodendrocytes and astrocytes and causes neuronal
cell death (Lu et al., 2001). This raises additional ques-
tions about the relationships among oligodendrocytes,
neurons, and astrocytes during development and be-
tween the molecular mechanisms of cell diversification
in the spinal cord and brain (e.g., Tekki-Kessaris et al.,
2001).
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